Stock 3933 THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages The United Laboratories International Holdings Limited

Equities

3933

KYG8813K1085

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:20 26/04/2024 pm IST 		5-day change 1st Jan Change
9.48 HKD -2.97% Intraday chart for The United Laboratories International Holdings Limited -1.15% +35.24%
27/03 The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
27/03 The United Laboratories International's 2023 Profit Rises on Higher Revenue MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
The United Laboratories International's 2023 Profit Rises on Higher Revenue
The United Laboratories International Holdings Limited Recommends Payment of Final Dividend for the Year Ended 31 December 2023
The United Laboratories International Holdings Limited Recommends Payment of Special Dividend for the Year Ended 31 December 2023
The United Laboratories International Forecasts Profit Surge in 2023
The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
United Laboratories Postpones EGM Due to Bad Weather
United Laboratories Subsidiary Gets US FDA Nod for Injectable for Diabetes; Shares Rise 8%
The United Laboratories International Holdings Limited Announces FDA Approval of IND for UBT251 Injection
The United Laboratories International Holdings Limited Announces Interim Dividend for Six Months Ended 30 June 2023, Payable on 11 October 2023
United Laboratories Controlling Shareholder to Sell 64 Million Shares
United Laboratories International Unit Gets Regulatory Nod to Conduct Trial on TUL01101 Tablets
Chinese Regulator Allows Clinical Trial of United Laboratories' Fatty-Liver Drug
The United Laboratories International Holdings Limited Announces Application for the Clinical Trial of Class 1 Innovative New Drug UBT251 Injection
United Laboratories International Says Two Products Pass Consistency Evaluation
China Greenlights United Laboratories' Clinical Trial for Obesity Injection; Shares Rise 4%
The United Laboratories International Holdings Limited Announces Approval for Clinical Trial of Ubt251 Injection on Indication of Overweight or Obesity
The United Laboratories International Holdings Limited Announces Ordinary Interim (Semi-Annual) Dividend for Six Months Ended 30 June 2023
United Laboratories' H1 Profit Doubles; Shares Fall 4%
The United Laboratories International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3933 Stock
  4. News The United Laboratories International Holdings Limited
  5. Other languages